Sanaa Chala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sanaa Chala has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Redouane Abouqal
Biostatistics Laboratory, Clinical Epidemiology Research. Faculty of Medicine and Pharmacy Mohammed V University in Rabat Rabat Morocco
9 shared publications Faïza Abdallaoui
Mohammed V University
4 shared publicationsFaiza Abdallaoui
3 shared publicationsMajid Sakout
Department of Endodontics and Restorative Dentistry, Faculty of Dental Medicine, Mohammed V University in Rabat, Rue Mohammed Jazouli, BP 6212 Madinat Al Irfane, Rabat, Morocco
3 shared publications- Akhilanand Chaurasia
Department of Oral Medicine and Radiology, King George’s Medical University, Lucknow, India
2 shared publications - Amal Thimou Izgua
Center of Consultations and External Explorations, HER, CHU Ibn Sina, Rabat, Morocco
2 shared publications
Latest Publications
- Open Access
- 4 October 2026
- Published by MDPI AG in Dentistry Journal
- Vol. 14 (10) , 638
Alternative Strategies for Managing Dental Black Stains: A Systematic Review
Background/Objectives: Dental black stains (BSs) are a form of extrinsic tooth discoloration of bacterial origin, with a prevalence ranging from 2.4% to 20%. As scaling and polishing remain the standard of care, recurrence is frequent. Therefore, this systematic review assessed alternative or adjunctive treatments, such as probiotics, chemical agents, and photodynamic therapy, for managing BSs. The primary objective was to evaluate clinical changes in BS recurrence and severity, while the secondary objective was to analyze microbiological changes. Methods: Conducted following PRISMA 2020 guidelines and registered on PROSPERO (CRD420261357137), this review searched PubMed, Cochrane Library, Scopus, Web of Science, and Dentistry & Oral Sciences Source through EBSCOhost as well as clinical trial registers (ClinicalTrials.gov and ISRCTN) and grey literature, up to 30 April 2026, with no language or date restrictions. We included randomized and non-randomized clinical trials. Two independent reviewers performed study selection and data extraction; a third resolved disagreements. We assessed risk of bias using RoB 2 and ROBINS-I V2, and quality of evidence using GRADE. Results: Of 716 records identified, eight clinical trials (five randomized clinical trials and three non-randomized clinical trials were included), with 250 patients enrolled and 227 assessed at follow-up. Four intervention categories were investigated: probiotics, antimicrobial mouthwashes (0.1%, 0.12% chlorhexidine and 0.1% chlorine dioxide), enzyme-containing toothpaste, and antimicrobial photodynamic therapy (aPDT). Probiotics may reduce BS indices, though the effect was inconsistent over time. In a single small, randomized study, chlorine dioxide showed a short-term reduction in bacterial viability greater than chlorhexidine. aPDT and enzyme-containing toothpaste did not show a significant benefit in the included studies. High risk of bias, heterogeneity, and the small sample prevented quantitative synthesis. Conclusions: Evidence supporting alternative strategies for managing recurrent dental BSs or reducing chromogenic bacterial load remains insufficient. Larger RCTs with standardized outcomes and longer follow-up are needed.
- 4 October 2026
- Published by MDPI AG in Dentistry Journal
- Vol. 14 (10) , 638
Open AccessAlternative Strategies for Managing Dental Black Stains: A Systematic Review
Background/Objectives: Dental black stains (BSs) are a form of extrinsic tooth discoloration of bacterial origin, with a prevalence ranging from 2.4% to 20%. As scaling and polishing remain the standard of care, recurrence is frequent. Therefore, this systematic review assessed alternative or adjunctive treatments, such as probiotics, chemical agents, and photodynamic therapy, for managing BSs. The primary objective was to evaluate clinical changes in BS recurrence and severity, while the secondary objective was to analyze microbiological changes. Methods: Conducted following PRISMA 2020 guidelines and registered on PROSPERO (CRD420261357137), this review searched PubMed, Cochrane Library, Scopus, Web of Science, and Dentistry & Oral Sciences Source through EBSCOhost as well as clinical trial registers (ClinicalTrials.gov and ISRCTN) and grey literature, up to 30 April 2026, with no language or date restrictions. We included randomized and non-randomized clinical trials. Two independent reviewers performed study selection and data extraction; a third resolved disagreements. We assessed risk of bias using RoB 2 and ROBINS-I V2, and quality of evidence using GRADE. Results: Of 716 records identified, eight clinical trials (five randomized clinical trials and three non-randomized clinical trials were included), with 250 patients enrolled and 227 assessed at follow-up. Four intervention categories were investigated: probiotics, antimicrobial mouthwashes (0.1%, 0.12% chlorhexidine and 0.1% chlorine dioxide), enzyme-containing toothpaste, and antimicrobial photodynamic therapy (aPDT). Probiotics may reduce BS indices, though the effect was inconsistent over time. In a single small, randomized study, chlorine dioxide showed a short-term reduction in bacterial viability greater than chlorhexidine. aPDT and enzyme-containing toothpaste did not show a significant benefit in the included studies. High risk of bias, heterogeneity, and the small sample prevented quantitative synthesis. Conclusions: Evidence supporting alternative strategies for managing recurrent dental BSs or reducing chromogenic bacterial load remains insufficient. Larger RCTs with standardized outcomes and longer follow-up are needed.
- Open Access
- 18 February 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (2) , 109446
Effect of Dentin Biomodification on the Survival of Resin Composite Restorations: An Umbrella Review
- 18 February 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (2) , 109446
Open AccessEffect of Dentin Biomodification on the Survival of Resin Composite Restorations: An Umbrella Review
- Open Access
- 1 September 2025
- Published by MDPI AG in Microbiology Research
- Vol. 16 (9) , 194
The Oral Bacteriome
The oral microbiome has garnered significant interest in recent years. Its profound implications for oral and systemic diseases have led to a considerable amount of research and analysis aimed at providing deeper insights into its composition. This study aimed to characterize oral bacterial communities comprehensively based on microorganisms indexed in the Human Oral Microbiome Database, which was systematically analyzed, and its taxonomic classification was used to describe the diversity of indexed bacteria in the oral cavity. A total of 522 bacteria were considered for the analysis. Among these, 49.04% were named, whereas 29.12% represent uncultivated phylotypes. The taxonomic characterization revealed that more than 80% of total taxa are distributed across five phyla: Bacillota, Bacteroidota, Actinomycetota, Pseudomonadota, and Fusobacteriota. Of these, Bacillota and Bacteroidota are the dominant ones with, respectively, 166 (31.80%) and 96 (18.39%) bacterial taxa. With the recent advances in genomics and bioinformatics, the HOMD is constantly updated, further enhancing our understanding of the bacterial community of the oral microbiome. However, the considerable diversity of the oral microbiome may present analytical challenges and the possible misperception of the implications of closely related species/subspecies in oral and systemic health.
- 1 September 2025
- Published by MDPI AG in Microbiology Research
- Vol. 16 (9) , 194
Open AccessThe Oral Bacteriome
The oral microbiome has garnered significant interest in recent years. Its profound implications for oral and systemic diseases have led to a considerable amount of research and analysis aimed at providing deeper insights into its composition. This study aimed to characterize oral bacterial communities comprehensively based on microorganisms indexed in the Human Oral Microbiome Database, which was systematically analyzed, and its taxonomic classification was used to describe the diversity of indexed bacteria in the oral cavity. A total of 522 bacteria were considered for the analysis. Among these, 49.04% were named, whereas 29.12% represent uncultivated phylotypes. The taxonomic characterization revealed that more than 80% of total taxa are distributed across five phyla: Bacillota, Bacteroidota, Actinomycetota, Pseudomonadota, and Fusobacteriota. Of these, Bacillota and Bacteroidota are the dominant ones with, respectively, 166 (31.80%) and 96 (18.39%) bacterial taxa. With the recent advances in genomics and bioinformatics, the HOMD is constantly updated, further enhancing our understanding of the bacterial community of the oral microbiome. However, the considerable diversity of the oral microbiome may present analytical challenges and the possible misperception of the implications of closely related species/subspecies in oral and systemic health.
- 12 March 2025
- Published by Springer Nature in Evidence-Based Dentistry
- Vol. 26 (3) , 146-147
Osteopontin as a prognostic biomarker in head and neck cancer– a systematic review and meta-analysis
Background Osteopontin (OPN) is linked to cancer progression, metastasis, and treatment resistance in head and neck cancer (HNC). This meta-analysis evaluated OPN as a prognostic biomarker in HNC. Method A comprehensive search was conducted for studies published up to December 2023, including English papers on HNC analyzing OPN expression. Data extraction, quality assessment, and quantitative analysis were performed using fixed and random effect models with 95% CI. Heterogeneity and publication bias were assessed with I2 and Egger’s regression test. Results Fifty-one studies were included. OPN expression was significantly elevated in tissue and plasma in HNC compared to control (SMD 0.98; 95% CI 0.47–1.49; I2 = 13%; p < 0.00). High plasma OPN predicted poor survival (HR: 2.00; I2 = 64%; P = 0.03), as did high tissue OPN (hazard ratio: 2.71, 95% confidence interval = 1.51–4.87; I2 = 49.4%, p > 0.05). Elevated plasma OPN correlated with smoking, poorly differentiated neoplasms, larger tumors, advanced stage, and lymph node metastasis. Positive tissue OPN was associated with nodal involvement, advanced stage, male gender, and smoking. Conclusion OPN is a robust prognostic biomarker in HNC, indicating tumor aggressiveness and poor prognostic outcomes. Standardized measurement protocols and further validation in prospective studies are necessary.
- 12 March 2025
- Published by Springer Nature in Evidence-Based Dentistry
- Vol. 26 (3) , 146-147
Osteopontin as a prognostic biomarker in head and neck cancer– a systematic review and meta-analysis
Background Osteopontin (OPN) is linked to cancer progression, metastasis, and treatment resistance in head and neck cancer (HNC). This meta-analysis evaluated OPN as a prognostic biomarker in HNC. Method A comprehensive search was conducted for studies published up to December 2023, including English papers on HNC analyzing OPN expression. Data extraction, quality assessment, and quantitative analysis were performed using fixed and random effect models with 95% CI. Heterogeneity and publication bias were assessed with I2 and Egger’s regression test. Results Fifty-one studies were included. OPN expression was significantly elevated in tissue and plasma in HNC compared to control (SMD 0.98; 95% CI 0.47–1.49; I2 = 13%; p < 0.00). High plasma OPN predicted poor survival (HR: 2.00; I2 = 64%; P = 0.03), as did high tissue OPN (hazard ratio: 2.71, 95% confidence interval = 1.51–4.87; I2 = 49.4%, p > 0.05). Elevated plasma OPN correlated with smoking, poorly differentiated neoplasms, larger tumors, advanced stage, and lymph node metastasis. Positive tissue OPN was associated with nodal involvement, advanced stage, male gender, and smoking. Conclusion OPN is a robust prognostic biomarker in HNC, indicating tumor aggressiveness and poor prognostic outcomes. Standardized measurement protocols and further validation in prospective studies are necessary.
- 1 October 2024
- Published by JLE in Cahiers Santé Médecine thérapeutique
- Vol. 33 (5) , 275-278
Bacterial cross-resistance to antibiotics and chlorhexidine: the role of oral biofilm bacteria
- 1 October 2024
- Published by JLE in Cahiers Santé Médecine thérapeutique
- Vol. 33 (5) , 275-278
Bacterial cross-resistance to antibiotics and chlorhexidine: the role of oral biofilm bacteria
- Open Access
- 27 August 2024
- Published by Elsevier in Journal of Dentistry
- Vol. 150, 105318
Core outcomes measures in dental computer vision studies (DentalCOMS)
- 27 August 2024
- Published by Elsevier in Journal of Dentistry
- Vol. 150, 105318
Open AccessCore outcomes measures in dental computer vision studies (DentalCOMS)
- 5 June 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 110 (6) , 1279-1284
Application of Genomic Medicine in Africa: 14th Conference of the African Society of Human Genetics and the 2nd International Congress of the Moroccan Society of Genomics and Human Genetics, Rabat, Morocco 2022
: The 14th African Society of Human Genetics (AfSHG) Morocco Meeting and 2nd International Congress of the Moroccan Society of Genomics and Human Genetics (SM2GH), held in Rabat, Morocco, from December 12 through 17, 2022, brought together 298 attendees from 23 countries, organized by the AfSHG in collaboration with the SM2GH. The conference’s overarching theme was “Applications of Genomics Medicine in Africa,” covering a wide range of topics, including population genetics, genetics of infectious diseases, hereditary disorders, cancer genetics, and translational genetics. The conference aimed to address the lag in the field of genetics in Africa and highlight the potential for genetic research and personalized medicine on the continent. The goal was to improve the health of African populations and global communities while nurturing the careers of young African scientists in the field. Distinguished scientists from around the world shared their recent findings in genetics, immunogenetics, genomics, genome editing, immunotherapy, and ethics genomics. Precongress activities included a 2-day bioinformatics workshop, “NGS Analysis for Monogenic Disease in African Populations,” and a Young Investigators Forum, providing opportunities for young African researchers to showcase their work. The vast genetic diversity of the African continent poses a significant challenge in investigating and characterizing public health issues at the genetic and functional levels. Training, research, and the development of expertise in genetics, immunology, genomics, and bioinformatics are vital for addressing these challenges and advancing genetics in Africa. The AfSHG is committed to leading efforts to enhance genetic research, coordinate training, and foster research collaborations on the continent.
- 5 June 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 110 (6) , 1279-1284
Application of Genomic Medicine in Africa: 14th Conference of the African Society of Human Genetics and the 2nd International Congress of the Moroccan Society of Genomics and Human Genetics, Rabat, Morocco 2022
: The 14th African Society of Human Genetics (AfSHG) Morocco Meeting and 2nd International Congress of the Moroccan Society of Genomics and Human Genetics (SM2GH), held in Rabat, Morocco, from December 12 through 17, 2022, brought together 298 attendees from 23 countries, organized by the AfSHG in collaboration with the SM2GH. The conference’s overarching theme was “Applications of Genomics Medicine in Africa,” covering a wide range of topics, including population genetics, genetics of infectious diseases, hereditary disorders, cancer genetics, and translational genetics. The conference aimed to address the lag in the field of genetics in Africa and highlight the potential for genetic research and personalized medicine on the continent. The goal was to improve the health of African populations and global communities while nurturing the careers of young African scientists in the field. Distinguished scientists from around the world shared their recent findings in genetics, immunogenetics, genomics, genome editing, immunotherapy, and ethics genomics. Precongress activities included a 2-day bioinformatics workshop, “NGS Analysis for Monogenic Disease in African Populations,” and a Young Investigators Forum, providing opportunities for young African researchers to showcase their work. The vast genetic diversity of the African continent poses a significant challenge in investigating and characterizing public health issues at the genetic and functional levels. Training, research, and the development of expertise in genetics, immunology, genomics, and bioinformatics are vital for addressing these challenges and advancing genetics in Africa. The AfSHG is committed to leading efforts to enhance genetic research, coordinate training, and foster research collaborations on the continent.
- 1 December 2023
- Published by JLE in Cahiers Santé Médecine thérapeutique
- Vol. 32 (6) , 297-301
Chlorhexidine: Its effects on oral biofilm and applications
- 1 December 2023
- Published by JLE in Cahiers Santé Médecine thérapeutique
- Vol. 32 (6) , 297-301
Chlorhexidine: Its effects on oral biofilm and applications
- 1 June 2023
- Published by JLE in Cahiers Santé Médecine thérapeutique
- Vol. 33 (3) , 88-91
Anti-cavity mouthwashes: active ingredients and effectiveness
- 1 June 2023
- Published by JLE in Cahiers Santé Médecine thérapeutique
- Vol. 33 (3) , 88-91
Anti-cavity mouthwashes: active ingredients and effectiveness